Title:
ＢＣＭＡ標的化キメラ抗原受容体
Document Type and Number:
Japanese Patent JP2023553390
Kind Code:
A
Abstract:
本開示は、ＢＣＭＡ標的化キメラ抗原受容体（ＣＡＲ）、並びにその調製方法及び用途を提供する。本開示のＣＡＲは、ＢＣＭＡ陽性細胞を標的とし、ＢＣＭＡ陽性Ｂ細胞リンパ腫、多発性骨髄腫及び形質細胞白血病を治療するために使用され得る。【選択図】図２２
More Like This:
Inventors:
Yao, Ehon
Juan, Jerchi
Yao, Shin
Juan, Jerchi
Yao, Shin
Application Number:
JP2023533391A
Publication Date:
December 21, 2023
Filing Date:
December 01, 2021
Export Citation:
Assignee:
Shanghai Cellular Biopharmaceutical Group Limited
International Classes:
C12N15/62; A61K9/08; A61K35/17; A61K39/00; A61P35/00; A61P35/02; C07K14/725; C07K16/28; C07K19/00; C12N5/10; C12N15/12; C12N15/13; C12N15/63
Attorney, Agent or Firm:
Makoto Ono
Kennori Kanayama
Yoshiyuki Tsubokura
Kazuki Shigemori
Kenji Ando
Hidehiko Ichikawa
Yoshie Sakurada
Yosuke Kawasaki
Youichi Iino
Yusuke Ichikawa
Sohei Aya
Takahiro Suzuki
Youhei Ogasawara
Yoshikazu Iwase
Yasufumi Shiroyama
Kennori Kanayama
Yoshiyuki Tsubokura
Kazuki Shigemori
Kenji Ando
Hidehiko Ichikawa
Yoshie Sakurada
Yosuke Kawasaki
Youichi Iino
Yusuke Ichikawa
Sohei Aya
Takahiro Suzuki
Youhei Ogasawara
Yoshikazu Iwase
Yasufumi Shiroyama